ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 515.00
-10.00 (-1.90%)
Sep 25, 2026, 4:59 PM CET
ChemoMetec Income Statement
Financials in millions DKK. Fiscal year is July - June.
Millions DKK. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 511.06 | 495.57 | 407.35 | 442.27 | 427.16 |
Other Revenue | - | - | 0.52 | 2.13 | 1.23 |
| 511.06 | 495.57 | 407.87 | 444.4 | 428.39 | |
Revenue Growth | 3.13% | 21.50% | -8.22% | 3.74% | 52.38% |
Cost of Revenue | 25.06 | 30.06 | 40.28 | 32.9 | 44.14 |
Gross Profit | 485.99 | 465.51 | 367.6 | 411.5 | 384.25 |
Selling, General & Admin | 204.74 | 207.46 | 181.42 | 160.47 | 161.36 |
Operating Expenses | 235 | 228.99 | 198.63 | 180.94 | 181.4 |
Operating Income | 251 | 236.52 | 168.97 | 230.56 | 202.85 |
Interest Expense | -0.39 | -0.63 | -0.18 | -1.09 | -1.52 |
Interest & Investment Income | 3.5 | 5.9 | 8.08 | 2.46 | 0.01 |
Currency Exchange Gain (Loss) | 4.07 | -16.79 | -0.27 | -1.57 | 1.87 |
Other Non Operating Income (Expenses) | - | 0 | - | - | 0 |
EBT Excluding Unusual Items | 258.17 | 225 | 176.59 | 230.36 | 203.22 |
Pretax Income | 258.17 | 225 | 176.59 | 230.36 | 203.22 |
Income Tax Expense | 56.34 | 50.31 | 40.3 | 51.69 | 43.75 |
Net Income | 201.84 | 174.7 | 136.28 | 178.67 | 159.47 |
Net Income to Common | 201.84 | 174.7 | 136.28 | 178.67 | 159.47 |
Net Income Growth | 15.53% | 28.19% | -23.72% | 12.04% | 80.49% |
Shares Outstanding (Basic) | 17 | 17 | 17 | 17 | 17 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 17 | 17 |
Shares Change | -0.03% | - | - | - | - |
EPS (Basic) | 11.60 | 10.04 | 7.83 | 10.27 | 9.16 |
EPS (Diluted) | 11.60 | 10.04 | 7.83 | 10.27 | 9.16 |
EPS Growth | 15.55% | 28.21% | -23.73% | 12.08% | 80.42% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 182.05 | 177.58 | 108.06 | 132.97 | 137.76 |
Free Cash Flow Per Share | 10.46 | 10.20 | 6.21 | 7.64 | 7.92 |
Dividend Per Share | - | 7.000 | 4.000 | 6.000 | - |
Dividend Growth | - | 75.00% | -33.33% | 50.00% | - |
Gross Margin | 95.10% | 93.93% | 90.13% | 92.60% | 89.70% |
Operating Margin | 49.11% | 47.73% | 41.43% | 51.88% | 47.35% |
Profit Margin | 39.49% | 35.25% | 33.41% | 40.20% | 37.23% |
Free Cash Flow Margin | 35.62% | 35.83% | 26.49% | 29.92% | 32.16% |
EBITDA | 265.88 | 247.68 | 178.78 | 244.49 | 216.65 |
EBITDA Margin | 52.02% | 49.98% | 43.83% | 55.02% | 50.57% |
D&A For EBITDA | 14.88 | 11.17 | 9.82 | 13.93 | 13.8 |
EBIT | 251 | 236.52 | 168.97 | 230.56 | 202.85 |
EBIT Margin | 49.11% | 47.73% | 41.43% | 51.88% | 47.35% |
Effective Tax Rate | 21.82% | 22.36% | 22.82% | 22.44% | 21.53% |